Cervical cancer is one of the few cancers we can almost entirely prevent. Screening finds the changes that come before cancer, years before they would ever become dangerous, and treats them while they are still easy to treat. The tools for doing that changed meaningfully in 2026, and for the first time, one of them does not require a speculum exam or even a trip to my office. If you have been putting off screening because you dislike the exam, this year's news is for you.
I want to lay out where cervical screening stands now: what a Pap smear actually is, how HPV testing works, the new self-collection option and who qualifies for it, what the vaccine does, and what happens when a result comes back abnormal. This is the conversation I have with patients, put in one place.
What is a Pap smear?
A Pap smear, also called a Pap test or cervical cytology, is a test that looks at cells from your cervix under a microscope to find changes that could become cancer. During the test, a clinician uses a speculum to see the cervix and a small brush or spatula to gently collect cells. Those cells go to a lab, where they are examined for abnormalities. The Pap test has been used for decades, and it is the reason cervical cancer deaths have fallen dramatically since the mid-twentieth century.
The Pap does not test for HPV directly; it looks at the consequences of HPV, the cellular changes the virus causes over time. This is why the newer approach matters: HPV testing catches the problem one step earlier, detecting the virus itself before it has changed the cells.
What is an HPV test, and how is it different?
Human papillomavirus is the cause of nearly all cervical cancers. An HPV test looks for the high-risk types of the virus in a cervical or vaginal sample, rather than waiting to see cell changes. Because it detects the underlying cause, HPV testing finds more precancers earlier than a Pap alone, which is why it has become the preferred screening method for most women.1,9
There are three screening approaches, and it helps to see them side by side.
| Method | What it does | Interval |
|---|---|---|
| Primary HPV test | Tests for high-risk HPV; the preferred method (ACS applies it from age 25, federal HRSA guidance from age 30) | Every 5 years |
| Co-testing (HPV + Pap) | Runs both tests together | Every 5 years |
| Pap test alone | Looks at cell changes only; used when HPV testing is unavailable | Every 3 years |
The 2026 change: at-home self-collection
This is the development patients have been asking me about. In 2024, the FDA first approved self-collection of an HPV sample in a clinical setting. In May 2025, it approved the first at-home self-collection kit.8 Then, on January 5, 2026, the Health Resources and Services Administration updated the federal screening guidelines to recommend self-collection as an option for average-risk women aged 30 to 65, and designated HPV testing, whether collected by the patient or a clinician, as the preferred screening method for that age group. The American Cancer Society, in its December 2025 update, accepts self-collected specimens across a slightly wider range, ages 25 to 65.2,3
Self-collection means exactly what it sounds like. Instead of a speculum exam, you use a swab to collect a sample from your vagina yourself, in private, either in a bathroom at the office or at home with an FDA-approved kit. The sample goes to a lab and is tested for high-risk HPV. Studies, including the SELF-CERV trial of the Teal Wand device, found self-collected samples to be similarly accurate to clinician-collected ones for HPV detection.3,4
Who can and cannot use self-collection
Self-collection is for average-risk women aged 30 to 65. It is not appropriate for everyone. Women at higher risk, including those with HIV, those who are immunocompromised, those exposed to diethylstilbestrol in utero, or those treated for cervical intraepithelial neoplasia grade 2 or higher within the past 20 years, should have clinician-collected samples.2 Women aged 21 to 29 are still recommended to have Pap tests every three years rather than self-collection.
One caution I give patients: the FDA-approved kits are only available through a healthcare provider or a legitimate telehealth service, not off a random website. HPV tests you order yourself from an unvetted online seller may not be reliable. Use an FDA-approved test.5
When to start, when to stop
| Age | Recommendation |
|---|---|
| Under 21 | No screening |
| 21-29 | Pap test every 3 years |
| 25-65 (ACS) | Primary HPV test every 5 years preferred; self-collected specimens acceptable in this range (repeat every 3 years if self-collected and HPV negative) |
| 30-65 | HPV testing (clinician- or self-collected) preferred every 5 years, or co-testing every 5 years, or Pap every 3 years |
| Over 65 | May stop if adequate prior negative screening, with a negative HPV test at or after age 65 |
There is a nuance about stopping. The American Cancer Society updated its guidance so that exiting screening requires a documented negative HPV test at ages 60 and 65, because too many cases were occurring in women over 65 who had stopped screening prematurely or without adequate prior testing.1 If you are approaching 65, do not assume you are finished until you and your clinician confirm your prior results meet the exit criteria.10
The HPV vaccine
The most powerful cervical cancer prevention happens before screening ever comes into play: avoiding the high-risk HPV infection to begin with. The HPV vaccine, Gardasil 9, protects against nine types of the virus, including HPV-16 and HPV-18, which together cause about 70 percent of cervical cancers, and five additional high-risk types that cause roughly another 20 percent. It also covers HPV-6 and HPV-11, which cause about 90 percent of genital warts.6,7
The CDC recommends routine vaccination at ages 11 or 12, though the series can start as early as 9. Given young, it is a two-dose series; started at 15 or older, it is three doses. The vaccine is approved through age 45, and adults up to 45 who were not vaccinated earlier can discuss catch-up vaccination with their clinician.7
An important point I make to every vaccinated patient: the vaccine does not replace screening. It does not cover every cancer-causing HPV type, and it does not treat an infection you may already have. You still need regular cervical screening even if you were fully vaccinated.
What HPV symptoms look like
This surprises many patients: high-risk HPV, the kind that causes cancer, usually causes no symptoms at all. There is no discharge, no pain, no visible sign. Screening exists precisely because the infection is silent. You cannot feel a high-risk HPV infection, and you cannot feel the precancerous changes it causes. By the time cervical cancer produces symptoms such as abnormal bleeding, bleeding after intercourse, or pelvic pain, it is usually more advanced.
The low-risk types, HPV-6 and HPV-11, can cause genital warts, which are visible and sometimes the only outward sign of HPV anyone notices. But warts are caused by the types that do not cause cancer. Their presence or absence tells you nothing about your cervical cancer risk, which is why screening, not symptom-watching, is the tool that protects you.
What an abnormal result means
An abnormal screening result is common and rarely means cancer; it means something needs a closer look. What happens next depends on the specific finding.
| Result | What it means | Typical next step |
|---|---|---|
| HPV positive, types 16/18 | Two highest-risk types detected | Colposcopy (a closer exam of the cervix) |
| HPV positive, other high-risk types | High-risk HPV other than 16/18 | Often a Pap to triage, then colposcopy if indicated |
| ASC-US with positive HPV | Slightly abnormal cells plus HPV | Colposcopy |
| ASC-US with negative HPV | Slightly abnormal cells, no high-risk HPV | Usually repeat screening; low risk |
| LSIL / HSIL | Low- or high-grade cell changes | Colposcopy, with treatment if higher-grade changes are confirmed |
A colposcopy is simply a magnified look at the cervix, often with a small biopsy, done in the office. It is a diagnostic step, not a treatment, and it is how we tell the difference between changes that will resolve on their own and changes that need treatment. Most abnormal results do not progress to cancer, especially when they are caught and followed appropriately.
What I tell patients
Getting screened at all matters more than which test you pick. The women who develop cervical cancer are overwhelmingly the ones who were not screened. Whatever method fits your life, the important thing is to actually do it.
Self-collection is a real option now, and it is for the women who were avoiding the exam. If the pelvic exam is what has kept you away, this removes that reason. Ask your provider about an FDA-approved self-collection test.
HPV testing is preferred because it catches problems earlier. If you are 30 or older, primary HPV testing every five years is now the recommended approach, and it is more sensitive than a Pap alone.
The vaccine and screening are partners, not substitutes. Even if you were vaccinated, you still need to be screened. The vaccine prevents most, not all, cancer-causing HPV.
An abnormal result is usually not cancer. It is a signal to look closer. Most abnormalities are managed with monitoring or a minor office procedure, not with a cancer diagnosis.
Do not stop screening early without confirming. The exit criteria at 65 exist for a reason. Confirm your prior results before assuming you are done.
Frequently asked questions
Can I test for HPV or do a Pap smear at home?
As of 2026, you can do at-home HPV self-collection if you are an average-risk woman aged 30 to 65, using an FDA-approved kit obtained through a provider or legitimate telehealth service. You collect a vaginal swab yourself and send it to a lab. A traditional Pap smear, which looks at cervical cells, still requires a clinician to collect the sample. Self-collection tests for HPV, not cervical cytology.
How accurate is HPV self-collection compared to a doctor's test?
Studies, including the SELF-CERV trial, found self-collected vaginal samples similarly accurate to clinician-collected samples for detecting high-risk HPV. Major guidelines now accept self-collection as an option for average-risk women aged 30 to 65. Clinician-collected samples are still preferred for higher-risk individuals, such as those who are immunocompromised or have a history of significant cervical changes.
How often do I need cervical cancer screening?
For average-risk women aged 30 to 65, primary HPV testing (clinician- or self-collected) every five years is preferred, co-testing with HPV and Pap every five years is an option, and a Pap alone every three years is acceptable if HPV testing is unavailable. Women aged 21 to 29 should have a Pap test every three years. Screening is generally not needed before 21.
What are the symptoms of HPV?
High-risk HPV, the kind that causes cervical cancer, usually causes no symptoms at all, which is why screening is essential. Low-risk types can cause genital warts, but those types do not cause cancer. Because cancer-causing HPV is silent, you cannot rely on symptoms; regular screening is the only way to catch changes early.
Does the HPV vaccine mean I no longer need Pap smears?
No. The HPV vaccine (Gardasil 9) prevents most but not all cancer-causing HPV types, and it does not treat an infection you may already have. You still need regular cervical cancer screening even if you were fully vaccinated. The vaccine and screening work together.
I tested HPV positive. Does that mean I have cancer?
No. A positive HPV test means a high-risk type was detected, not that you have cancer. Most HPV infections clear on their own. Depending on which type and your cell results, the next step is usually monitoring or a colposcopy, a magnified look at the cervix. Think of a positive result as a prompt to look closer rather than a cancer diagnosis.
When can I stop cervical cancer screening?
Average-risk women can generally stop at age 65 if they have adequate prior negative screening, including a negative HPV test at or after age 65. Because too many cancers occur in women who stopped prematurely, current guidance requires documented negative HPV tests at ages 60 and 65 before exiting. Confirm your prior results with your clinician before stopping.
References
- Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: an update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;76(1):e70041. doi:10.3322/caac.70041. PMC12677112
- Health Resources and Services Administration. New Cervical Cancer Screening Guidelines Strengthen Women's Preventive Health. January 5, 2026. hrsa.gov
- Society of Gynecologic Oncology. HRSA Announces Updated Cervical Cancer Screening Guidelines. January 2026. sgo.org
- SELF-CERV trial (NCT06120205): evaluation of the Teal Wand self-collection device for HPV testing. Teal Health. Results reported 2025.
- American Cancer Society. Cervical Cancer Screening Guidelines: note on FDA-approved self-collection devices and caution regarding tests ordered online. Updated December 2025. cancer.org
- Cleveland Clinic. HPV Vaccine: types covered and cancers prevented. Updated 2026. clevelandclinic.org
- Centers for Disease Control and Prevention. HPV Vaccination: Information for Health Care Providers; Administering HPV Vaccine (dosing and schedule). Updated 2026. cdc.gov
- US Food and Drug Administration. FDA approvals for HPV self-collection: in-clinic self-collection (2024) and first at-home self-collection kit (May 2025).
- US Preventive Services Task Force. Screening for Cervical Cancer: recommendation including self-collected HPV testing for women aged 30 to 65. 2024. uspreventiveservicestaskforce.org
- Fontham ETH, Wolf AMD, Church TR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70(5):321-346. PMID 32729638
- World Health Organization. Cervical cancer fact sheet: global burden and 2022 incidence data. 2024. who.int
This article is educational and does not constitute medical advice or establish a physician-patient relationship. Screening decisions should be made with a qualified clinician who knows your history and risk factors. Consult your own physician about the right screening approach for you.